Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
One of the challenges in treating patients with heart failure (HF) is achieving clinical
stability and reducing the hospital readmission rate. A diuretic dose adjustment algorithm
developed in the United States (Diuretic Treatment Algorithm, DTA) and later validated for
use in Brazil (as the Algoritmo de Ajuste de Diurético, AAD) has proved feasible and readily
applicable, but its effect on clinical outcomes has yet to be assessed. This report aims to
describe a randomized clinical trial protocol designed to assess the effectiveness of the AAD
and of nonpharmacologic management in improving clinical stability and reducing the
readmission rate at 90 days in patients with HF.